Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Experimental peptide vaccine is safe and effective in patients with CML

June 11, 1999

Japanese patents cover Daiichi's new diphenyl antitumor agents

June 11, 1999

Planned enrollment complete for IntraDose trial, additional patients included

June 11, 1999

LY-294002 induces apoptosis alone or in combination with other apoptosis-inducing agents

June 11, 1999

FDA advisory committee recommends approval of Ellence breast cancer treatment

June 11, 1999

Antitumor substance produced by Aspergillus discovered at Nippon Kayaku

June 10, 1999

Novel cytotoxic compound isolated from marine tunicate at Spanish research institute

June 10, 1999

FDA advisory committee recommends approval of Doxil sNDA

June 10, 1999

ODAC recommends approval of Ethyol for dry mouth

June 10, 1999

Protein kinase inhibitors from Glaxo for proliferative, metabolic and inflammatory disorders

June 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.